Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
With
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan
Age
1–8
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female asthmatic children with mild to moderate persistent asthma.
12 months to 8 years of age.
For children age 4 to 8 years: Documented diagnosis of asthma at least 3 months prior to Visit 1, per NIH (EPR-3) criteria.
For infants age 12 to \<48 months old: 2 or more wheezing episodes in past 12 months which lasted \> 1 day and affected sleep.
AND with at least one major or two minor risk factors.
You may not be if
Any other significant childhood illness/abnormality or chronic lung disease
Any history of upper or lower respiratory tract infection, within 2 weeks of screening.
Any history of acute or severe asthma attack requiring ICU admission or ventilatory support.
Use of any corticosteroid, including inhaled, parental, intranasal, or topical corticosteroid within 2 weeks of screening.
Any use of oral corticosteroids within 30 days of screening or prolonged use (\>10 consecutive days) of oral corticosteroids, within 12 weeks of screening.
